Charles Michaud Jr - Mar 25, 2024 Form 4 Insider Report for Q32 Bio Inc. (QTTB)

Role
Former Vice President, Corporate Controller and Treasurer of Homology Medicines, Inc.
Signature
/s/ Charles Michaud, Jr.
Stock symbol
QTTB
Transactions as of
Mar 25, 2024
Transactions value $
-$1,815
Form type
4
Date filed
4/23/2024, 05:00 PM
Previous filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QTTB Common Stock Sale -$1.82K -75 -7.49% $24.20* 927 Mar 25, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Charles Michaud Jr is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs.
F2 On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split.

Remarks:

Former Vice President, Corporate Controller and Treasurer of Homology Medicines, Inc.